期刊文献+

多囊卵巢综合征患者种植窗口期子宫内膜容受性的研究 被引量:10

Study on endometrium receptivity in patients with polycystic ovary syndrome during implantation window time
原文传递
导出
摘要 目的研究影响多囊卵巢综合征(PCOS)患者种植窗口期子宫内膜容受性的基因表达。方法 9例 PCOS 患者(PCOS 组)及7例非 PCOS 因男方原因不孕者(对照组)行阴道超声监测结合血清激素测定确定排卵时间,于种植窗口期对两组妇女进行子宫内膜活检,提取 cDNA,其中6例PCOS 患者应用含有21571个基因序列的寡核苷酸芯片进行扫描,经过分析后得到 PCOS 患者的子宫内膜与对照组相比的差异表达基因;另外3例 PCOS 患者进行实时荧光定量 PCR 实验检测基质金属蛋白酶26(MMP-26)基因的表达。结果 PCOS 患者种植窗口期子宫内膜的差异表达基因为116个,占全部表达基因的比例为1.23%(116/9421)。PCOS 组患者与对照组比较,表达上调的差异表达基因占0.12%(11/9421);表达下调的差异表达基因占1.11%(105/9421),其中,MMP-26在基因芯片中表达下调10.6倍。与对照组患者种植窗口期子宫内膜比较,3例 PCOS 患者子宫内膜 MMP-26基因的相对表达率(Ratio 值)分别为0.31、0.11和0.05。结论 PCOS 患者种植窗口期子宫内膜 MMP-26基因表达下调,提示 PCOS 患者存在子宫内膜容受能力下降。 Objective To explore the gene which might influence endometrium receptivity during the implantation window time in normal women and patients with polycystic ovary syndrome (PCOS). Methods Transvaginal ultrasound were performed and serum estrogen and progestogen levels were measured in all women to monitor the exact time of ovulation. Endometrium biopsy was done in normal women and PCOS patients during implantation window time. Sixteen women were enrolled in this study, in which seven were normal women, and nine were PCOS patients, cDNA extraction was performed, matrix metalloproteinase 26 (MMP-26) primers were synthesized and real time fluorescent quantitative PCR was conducted using 13-actin gene as endogenous control. Results The ratios of MMP-26 were 0. 31, 0. 11 and 0. 05 in 3 patients with PCOS by real time fluorescent quantitative PCR, obviously decreased during implantation time compared with the normal women. Conclusions Our data suggest a lower expression of MMP-26 in implantation window time in patients with PCOS than in normal patients. This might indicate a declined capability of endometrium receptivity in implantation window time in patients with PCOS.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2007年第5期298-301,共4页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金(30570872)
关键词 多囊卵巢综合征 胚胎植入 子宫内膜 基质金属蛋白酶 基因表达调控 种植窗口期 Polycystic ovary syndrome Embryo implantation Endometrium Matrix metalloproteinases Gene expression regulation
  • 相关文献

参考文献16

  • 1Ghazeeri G, Kutteh WH, Bryer-Ash M, et al. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women polyeystic ovary syndrome. Fertil Steril, 2003, 79 : 562-566.
  • 2Dominguez F, Remohi J, Pellicer A, et al. Human endometrial receptivity: a genomic approach. Reprod Biomed Oneline, 2003, 6 : 332-338.
  • 3Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to palycystic ovary syndrome. Fertil Steril, 2004, 81: 19-25.
  • 4Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol, 1975, 122: 262-263.
  • 5Smid-Koopman E, Blok LJ, Chadha-Ajwani S, et aL Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method. Br J Cancer, 2000, 83: 246-251.
  • 6Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A, 1998, 95: 14863-14868.
  • 7Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res, 2001, 29: e45.
  • 8Adams EC, Hertig AT, Rock J. A description of 34 human ova within the first 17 days of development. Am J Anat, 1956, 98: 435-493.
  • 9Marchenko GN, Strongin AY. MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene, 2001, 265: 87-93.
  • 10Bai Sx, Wang YL, Qin L, et aL Dynamic expression of matrix metalloproteinases ( MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3 ) at the implantation site during tubal pregnancy. Reproduction, 2005, 129 : 103-113.

二级参考文献20

  • 1曾国庆,曹宇静.小鼠胚胎与子宫单层上皮细胞共培养的研究[J].动物学报,1996,42(2):212-217. 被引量:23
  • 2Sang Q A, Douglas D A. Computational sequence analysis of matrix metalloproteinases. J Protein Chem, 1996, 15: 137~160
  • 3Fisher S J, Damsky C H. Human cytotrophoblast invasion. Semin Cell Biol, 199
  • 4, 4: 183 ~ 1883 Marchenko G N, Strongin A Y. MMP-28, a new human matrix metalloproteinase withan unusual cysteine-switch sequence is widely expressed in tumors. Gene, 2001, 265: 87 ~ 93
  • 5Zhang Jian, Cao Yujing, Zhao Yunge, et al. Expression of matrix metalloproteinase-26 (MMP-26) and tissue inhibitor of metalloproteinases 4 (TIMP-4) in human normal cytotrophoblast cells and a choriocarcinoma cell line JEG-3. Mol Hum Reprod, 2002, 8(7): 659 ~ 666
  • 6Marchenko G N, Ratnikov B I, Rozanov D V, et al. Charac- terization of matrix metalloproteinase-26, a novel metallopro- teinase widely expressed in cancer cells of epithelial origin. Biochem J, 2001, 356 (Pt 3): 705 ~ 718
  • 7de Coignac A B, Elson G , Delneste Y, et al. Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem, 2000, 267: 3323 ~ 3329
  • 8Park H I, Ni J, Gerkema F E, et al. Identification and characterization of human endometase (Matrix metalloproteinase- 26) from endometrial tumor. J Biol Chem, 2000, 275: 20540 ~ 20544
  • 9Uria J A, Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressedin human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res, 2000, 60: 4745 ~ 4751
  • 10Schaeren-Wielemers N, Gerfin-Moser A. A single protocol to detect transcriptsof various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry, 1993,100: 431 ~ 440

共引文献1

同被引文献86

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部